GCN2 in proteostasis: structural logic, signalling networks and disease
The FEBS Journal · 2026
DOI: 10.1111/febs.70480 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The FEBS Journal, 2026. Verfasst von JiaYi Zhu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cambridge Institute for Medical Research (CIMR), University of Cambridge, UK. Hauptthemen laut MEDLINE: Proteostasis, Protein Serine-Threonine Kinases, Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 203 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alpha1 Foundation, Asthma + Lung UK, NIHR Cambridge Biomedical Research Centre.
Abstract (Originalsprache)
Proteostasis is the finely tuned balance of protein synthesis, folding and degradation essential for cellular health. When this equilibrium is disrupted, misfolded proteins accumulate, triggering adaptive stress responses such as the unfolded protein response and the integrated stress response (ISR). Central to the ISR is the kinase GCN2, a sensor of amino acid deprivation and ribosomal stress. Upon activation, GCN2 phosphorylates eIF2α, dampening global translation while selectively enhancing the synthesis of the stress‐responsive transcription factors ATF4 and CHOP. ATF4 orchestrates a broad transcriptional programme that supports amino acid metabolism, redox homeostasis, autophagy and proteasomal degradation, which are key processes for restoring proteostasis. Beyond its canonical role, GCN2 interfaces with other regulatory networks modulating mTORC1 to promote autophagic clearance of damaged proteins and organelles, facilitating stress granule formation, and integrating signals from oxidative and endoplasmic reticulum stress to rebalance the proteome. Dysregulated GCN2 activity has been implicated in diverse pathologies including neurodegeneration, cancer and pulmonary vascular disease, positioning it as a promising therapeutic target. In this review, we explore how GCN2 links nutrient sensing to translational control and metabolic adaptation, and how its central role in proteostasis may inform new strategies for treating diseases driven by protein misfolding and stress pathway imbalance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cambridge Institute for Medical Research (CIMR), University of Cambridge, UK.
- Department of Medicine, University of Cambridge, UK.
- Royal Papworth Hospital, NHS Foundation Trust, UK.
ORCID-Profile: Stefan J Marciniak
Förderung
- Alpha1 Foundation
- Asthma + Lung UK
- NIHR Cambridge Biomedical Research Centre
- Cambridge Trust Doctoral Training Programme in Medical Research
- DTP-MR Doctoral Training Programme in Medical Research
- Royal Papworth Hospital NHS Foundation Trust Chair in Respiratory Science
- Medical Research Council
- Cambridge Trust
Zitieren
APA
Zhu, J., & Marciniak, S. J. (2026). GCN2 in proteostasis: structural logic, signalling networks and disease. The FEBS Journal. https://doi.org/10.1111/febs.70480
Vancouver
Zhu J, Marciniak SJ. GCN2 in proteostasis: structural logic, signalling networks and disease. The FEBS Journal. 2026. doi:10.1111/febs.70480
BibTeX
@article{Zhu2026,
author = {Zhu, JiaYi and Marciniak, Stefan J},
title = {GCN2 in proteostasis: structural logic, signalling networks and disease},
journal = {The FEBS Journal},
year = {2026},
doi = {10.1111/febs.70480}
}
EUVIMED